Treatment options for Alzheimer's disease

Area of Science:

• Neuroscience
• Pathophysiology
• Molecular Biology

Background:

• Alzheimer's disease (AD) pathogenesis remains incompletely understood, with no single unifying theory.
• Multiple factors, including inflammation, oxidative stress, and genetic predispositions (e.g., apolipoprotein E), are implicated in AD development.
• Key molecular pathways, such as beta-amyloid42 production and cholinergic neuron depletion, are central to AD progression.

Purpose of the Study:

• To review the current understanding of Alzheimer's disease pathophysiology and molecular mechanisms.
• To explore various hypotheses regarding the development and progression of Alzheimer's disease.
• To summarize existing and potential therapeutic interventions for Alzheimer's disease.

Main Methods:

• Literature review of existing research on Alzheimer's disease.
• Analysis of proposed etiological factors and molecular pathways.
• Compilation of current therapeutic strategies and their mechanisms.

Main Results:

• Several factors contribute to Alzheimer's disease, including inflammation, oxidative stress, hormonal changes, and genetic factors.
• The article identifies specific molecular pathways like beta-amyloid production and cholinergic deficits as targets for intervention.
• Current therapeutic options include estrogen replacement therapy, Ginkgo biloba, and cholinesterase inhibitors (tacrine, donepezil).

Conclusions:

• Effective Alzheimer's disease treatment requires a comprehensive understanding of its complex pathophysiology.
• Targeting identified molecular mechanisms and etiological factors offers potential for novel therapeutic strategies.
• Existing treatments, while varied, aim to mitigate symptoms by addressing specific pathological pathways.